Clinical Trial Update: A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4+ T Cells > 350 Cells/mm3 [NA]

View source ↗

Summary

A pilot trial evaluating immunization with HIV-1 antigen-pulsed allogeneic dendritic cells in asymptomatic HIV-infected patients with CD4 counts over 350; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• HIV-1 antigen pulsed allogeneic dendritic cell vaccine (dendritic cell vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | NA | Status: TERMINATED